Biotech Series C Investors & VC Firms

430 firms in this list, with a median first check of $648K. 101 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Woodford Investment Management	Oxford	GB	Series A–Growth	—	+ Add to CRM
Ippon 1 person	Geneva	CH	Series A–Growth	—	+ Add to CRM
RecapHealth Ventures 1 person	Vancouver	CA	Seed–Late Stage	—	+ Add to CRM
Shanghai STVC Group 1 person	Shanghai	CN	Seed–Growth	—	+ Add to CRM
HSBC Innovation Ventures 1 person	London	GB	Seed–Growth	—	+ Add to CRM
Ilshin Investment Co. Ltd. 1 person	Seoul	KR	Seed–Late Stage	—	+ Add to CRM
3H Health Investment	Shanghai	CN	Series A–Late Stage	—	+ Add to CRM
Providence Investment Company Limited	Germany	US	Seed–Growth	—	+ Add to CRM
Lake Bleu Capital	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
Avlar BioVentures	Madingley	GB	Series A–Growth	—	+ Add to CRM
Hong Kong X Technology Fund	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
Candy Capital	—	GB	Seed–Growth	—	+ Add to CRM
Cdh Venture Management Company Limited	Hong Kong	HK	Series A–Series C	—	+ Add to CRM
EQT Fund Management S.à.r.l.	—	NL	Seed–Growth	—	+ Add to CRM
Future Fund: Breakthrough	—	GB	Series B–Growth	—	+ Add to CRM
Hunt BioVentures	Dallas	US	Seed–Growth	—	+ Add to CRM
SDIC Venture Capital / SDIC Fund Management	Beijing	CN	Seed–Growth	—	+ Add to CRM
XGen Venture SGR	—	IT	Seed–Growth	—	+ Add to CRM
Zero2IPO	Beijing	CN	Series A–Late Stage	—	+ Add to CRM